DIADIA0.58%
SPYSPY0.40%
QQQQQQ0.93%
Trending
Top trending tickerXMG0.00%
SCARCESCARCE2.19%
SSBSSB0.86%
SOLSOL0.87%
RCATRCAT7.21%
MERYMERY2.64%
PINSPINS0.34%
GSGS1.15%
LHX0.78%
TWST7.01%
Top trending tickerXMG0.00%
SCARCESCARCE2.19%
SSBSSB0.86%
SOLSOL0.87%
RCATRCAT7.21%
MERYMERY2.64%
PINSPINS0.34%
GSGS1.15%
LHX0.78%
TWST7.01%
homeSymbolDAWN

DAWN
Day One Biopharmaceuticals Inc

1,839
Mkt Cap
$903.54M
Volume
3.55M
52W High
$14.46
52W Low
$5.64
PE Ratio
-5.92
DAWN Fundamentals
Price
$8.97
Prev Close
$8.85
Open
$8.77
50D MA
$7.60
Beta
1.13
Avg. Volume
1.52M
EPS (Annual)
-$1.02
P/B
2.00
Rev/Employee
$724,646.41
Loading...
Loading...

Feed

News

Sentiment

Earnings

Fundamentals

Info

News
all
press releases
Day One Biopharmaceuticals Sees Unusually Large Options Volume (NASDAQ:DAWN)
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) was the recipient of unusually large options trading on Thursday. Stock investors purchased 3,055 call options on the stock. This is...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Down - Here's Why
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Down - Time to Sell...
MarketBeat·2d ago
News Placeholder
Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’
Mersana surged even as multiple firms downgraded the stock following Day One’s acquisition agreement.
Stocktwits·2d ago
News Placeholder
Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout
Day One Biopharmaceuticals plans to acquire Mersana Therapeutics in a deal worth up to $285 million to expand its cancer drug portfolio.read more...
Benzinga·3d ago
News Placeholder
Mersana Therapeutics To Be Acquired By Day One Biopharmaceuticals For Up To $285 Mln
(RTTNews) - Mersana Therapeutics, Inc. (MRSN), a biopharmaceutical company, Thursday, announced that it has entered a definitive agreement to be acquired by Day One Biopharmaceuticals through a...
Nasdaq News: Markets·3d ago
News Placeholder
MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal
The upfront purchase price of $25 alone represents a premium of 182% from Mersana’s closing price on Wednesday.
Stocktwits·3d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
JPMorgan Chase & Co. lifted their target price on shares of Day One Biopharmaceuticals from $26.00 to $27.00 and gave the company an "overweight" rating in a research report on Friday...
MarketBeat·7d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading 8.5% Higher - Here's Why
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Up 8.5% - Still a Buy...
MarketBeat·8d ago
News Placeholder
Equities Analysts Issue Forecasts for DAWN FY2025 Earnings
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) - HC Wainwright raised their FY2025 earnings per share estimates for Day One Biopharmaceuticals in a report released on Wednesday...
MarketBeat·8d ago
News Placeholder
What is Wedbush's Estimate for DAWN FY2025 Earnings?
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) - Equities research analysts at Wedbush increased their FY2025 earnings per share (EPS) estimates for shares of Day One Biopharmaceuticals...
MarketBeat·8d ago

Latest DAWN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.